chemo/immunotherapy in advanced squamous nsclc: what is the impact of impower131? (bmic-026)
Published 6 years ago • 267 plays • Length 9:15Download video MP4
Download video MP3
Similar videos
-
5:39
lung cancer video library - chemo immuno therapy combinations in advanced squamous nsclc
-
8:10
impower131: role for carbo/nab-paclitaxel/atezolizumab combo for adv. squamous nsclc? (bmic-041)
-
3:47
combining chemotherapy & immunotherapy in squamous nsclc
-
6:20
immunotherapy in stage iii nsclc: practice-changing results of pacific trial (bmic-006)
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
7:13
first-line pembrolizumab plus chemotherapy for patients with advanced squamous nsclc: 3-year fol...
-
2:54
advanced squamous nsclc: the impower131 study
-
8:46
keytruda is now approved in combination with chemo for advanced non-squamous nsclc
-
8:16
cutaneous squamous cell carcinoma: what is immunotherapy?
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
5:10
the role of immunotherapy in squamous nsclc
-
8:00
immunotherapy for squamous non-small cell lung cancer
-
1:50
anti-vegf therapy in advanced squamous nsclc
-
22:06
the basics of immunotherapy in non-small cell lung cancer (nsclc)
-
6:40
chemotherapy/immunotherapy combinations in lung cancer
-
4:23
management of patients with pdl1-high advanced nsclc
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
5:42
role of i/o with chemotherapy in advanced squamous nsclc
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team